Positive Results for AlzeCure’s Phase IIa clinical study in neuropathic pain with the non-opioid ACD440Published: May 29, 2023
Pharm Assist is now part of LINK Medical, making the Regulatory team one of the largest and unique in Northern EuropePublished: March 23, 2023
Last Patient Last Visit (LPLV) Milestone achieved for AlzeCure’s phase II clinical trial of the non-opioid ACD440 in neuropathic painPublished: March 14, 2023
Labiotech article: How clinical trials benefit from decentralized solutions: A Nordic case studyPublished: September 21, 2022 Another milestone reached for AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440Published: June 22, 2022
LINK Medical, the Northern European CRO has raised capital to fund further growthPublished: May 2, 2022